Centers for Disease Control and Prevention Annual Estimates of Influenza Vaccine Effectiveness for Preventing Medically Attended Laboratory- Confirmed Influenza in the United States
Agency: Centers for Disease Control and Prevention - ERA
Assistance Listings
- 93.185 -- Immunization Research, Demonstration, Public Information and Education_Training and Clinical Skills Improvement Projects
Archived opportunityLast Updated: May 13, 2026
View version history on Grants.gov
Description
Centers for Disease Control and Prevention Annual Estimates of Influenza Vaccine Effectiveness for Preventing Medically Attended Laboratory- Confirmed Influenza in the United States
Eligibility
Eligible applicants
Miscellaneous
- Other
Additional information
This award will be a continuation of funds intended only for grantees previously awarded under RFA-IP-16-002: Centers for Disease Control and Prevention Annual Estimates of Influenza Vaccine Effectiveness for Preventing Medically Attended Laboratory- Confirmed Influenza in the United States.
Grantor contact information
Description
Centers for Disease Control and Prevention (CDC)
Office of Grant Services (OGS)
Technical Information Management Section (TIMS)
Phone: 770-488-2700
ogstims@cdc.gov
Documents
| File name | Description | Last updated |
|---|---|---|
| RFA-IP16-00202CONT17_FINAL_02_08_17.docx | Centers for Disease Control and Prevention Annual Estimates of Influenza Vaccine Effectiveness for Preventing Medically Attended Laboratory- Confirmed Influenza in the United States | Feb 8, 2017 08:27 PM UTC |
Link to additional information
--
Archived: May 10, 2017
Award
$--
Program Funding
10
Expected awards
$--
Award Minimum
$--
Award Maximum
Funding opportunity number:
RFA-IP-16-00202CONT17
Cost sharing or matching requirement:
No
Funding instrument type:
Cooperative agreement
Opportunity Category:
Continuation
Opportunity Category Explanation:
--
Category of Funding Activity:
Health
Category Explanation:
--
History
Version:
1
Posted date:
February 8, 2017
Archive date:
May 10, 2017
